Gut microbiota can interact with the immune system through its metabolites. Short-chain fatty
acids (SCFAs), as one of the most abundant metabolites of the resident gut microbiota play …

Studies in human microbiota dysbiosis have shown that short-chain fatty acids (SCFAs) like
propionate, acetate, and particularly butyrate, positively affect energy homeostasis …

Background Diabetic retinopathy (DR) development is associated with disturbances in the
gut microbiota and related metabolites. Butyric acid is one of the short-chain fatty acids …

Diabetes is the leading cause of kidney disease, and as the number of individuals with
diabetes increases there is a concomitant increase in the prevalence of diabetic kidney …

Evidence indicates that short-chain fatty acids (SCFAs) generated from the gut microbiota
play crucial roles in host metabolism. They contribute to metabolic regulation and energy …

Butyrate produced by the gut microbiota has beneficial effects on metabolism and
inflammation. Butyrate-producing bacteria are supported by diets with a high fiber content …

Most patients with inflammatory bowel disease (IBD) develop anemia, which is attributed to
the dysregulation of iron metabolism. Reciprocally, impaired iron homeostasis also …

Microbial metabolites have emerged as key players in the interplay between diet, the gut
microbiome, and host health. Two major classes, short-chain fatty acids (SCFAs) and …

Diabetic nephropathy (DN), defined as continuously elevated urinary albumin and a
diminished estimated glomerular filtration rate, is a serious complication of both type 1 …

Gut microbiome-modulating agents (MMAs), including probiotics, prebiotics, postbiotics, and
synbiotics, are shown to ameliorate type 1 diabetes (T1D) by restoring the microbiome from …